|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Development of contraceptive vaccines for humans using antigens derived from |
| gametes (spermatozoa and zona pellucida) and hormones (human chorionic |
| gonadotrophin): current status. |
| Naz RK; Sacco A; Singh O; Pal R; Talwar GP |
| HUMAN REPRODUCTION UPDATE. 1995 Jan;1(1):1-18. |
| Contraceptive research has entered a new phase of development with the advent of hybridoma and DNA recombinant |
| technologies. During the past 5 years, significant advances have been made in this area, and now it seems that |
| realistic prospects exist for the development of contraceptive vaccines for use in humans and animals (veterinary, |
| wild and domestic), applicable to both the female and male sexes. Contraceptive vaccines will be valuable |
| supplements to the presently available methods of family planning, and, due to high specificity, the occurrence of |
| limited side-effects, if any, low cost and infrequent administration, contraceptive vaccines may have greater |
| acceptability than the currently available methods. Mammalian reproduction starts with the unison of gametes |
| contributed by the male and female partners. Both spermatozoon and oocyte have antigens on the cell surface that |
| are unique, tissue-specific, immunogenic and accessible to antibodies, and binding of the antibodies to these |
| antigens can cause inhibition of gamete function, resulting in a failure of fertilization. Fertilization is followed by |
| embryogenesis, with the early embryo producing several proteins, some of which, e.g., human chorionic gonadotropin |
| (HCG), have a vital role in the establishment and maintenance of early pregnancy. Again, these proteins are |
| accessible to antibodies, and their immunoneutralization can cause anti-fertility effects with loss of early embryos. |
| Thus, the antigens derived from proteins on spermatozoa, oocyte and early embryo, especially HCG, constitute |
| interesting molecules for the development of contraceptive vaccines. The aim of the present article is to review the |
| current status of development of contraceptive vaccines based on antigens derived from sperm cell, oocyte zona |
| pellucida and HCG, and to discuss their relative merits and future development. (PubHealth.info Document ID: |
| PubHealth.info NOTE: The author(s) of this article titled, "Development of contraceptive vaccines for humans using |
| antigens derived from gametes (spermatozoa and zona pellucida) and hormones (human chorionic gonadotrophin): |
| current status.", is(are) Naz RK; Sacco A; Singh O; Pal R; Talwar GP. The source of this article is "HUMAN |
| REPRODUCTION UPDATE. 1995 Jan;1(1):1-18.". This article was published in 1995 in English language(s). |
| (PubHealth.info® Document ID: CONT2T 2536-06. All rights reserved with PubHealth.info) PIN: 7536 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |